Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 2, 2006, Pages 214-223

  Robertson, Charlene M T ^a,c   Tyebkhan, Juzer M ^b,c   Peliowski, Abraham ^b,c   Etches, Philip C ^b,c   Cheung, Po Yin ^b,c  

^a GLENROSE REHABILITATION HOSPITAL   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Children; Neonatal respiratory failure; Ototoxic drugs; Sensorineural hearing loss

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ETACRYNIC ACID; FUROSEMIDE; GENTAMICIN; LOOP DIURETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; PANCURONIUM BROMIDE; TOBRAMYCIN; VANCOMYCIN; VECURONIUM;

ARTICLE; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HEARING TEST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; ONSET AGE; OTOTOXICITY; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT DURATION;

AMIKACIN; AMINOGLYCOSIDES; ANTI-INFECTIVE AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; DIURETICS; ETHACRYNIC ACID; FEMALE; FUROSEMIDE; GENTAMICINS; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT, NEWBORN; MALE; PANCURONIUM; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; TOBRAMYCIN; VANCOMYCIN; VECURONIUM BROMIDE;

EID: 31944452362     PISSN: 08035253     EISSN: 15023869     Source Type: Journal    
DOI: 10.1080/08035250500294098     Document Type: Article

References (44)

1. Borradori C, Fawer C-L, Buclin T, Calame A. Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate 1997;71:1-10.
2. Salamy A, Eldridge L, Tooley WH. Neonatal status and hearing loss in high risk infants. J Pediatr 1989;114:847-52.
3. Nield TA, Schrier S, Ramos AD, Platzker ACG, Warburton D. Unexpected hearing loss in high-risk infants. Pediatrics 1986;78:417-22.
4. Kawashiro N, Tsuchihashi N, Koga K, Itoh Y, Kawano H. Idiopathic deafness or hearing loss of unknown etiology following discharge from NICU. Acta Otolaryngol (Stockh) 1994;Suppl 541:81-4.
5. Marlow ES, Hunt LP, Marlow N. Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed 2000;82:F141-4.
6. Konkle KF, Knightly CA. Delayed onset hearing loss in respiratory distress syndrome. Case reports. J Am Acad Audio 1993;4:351-4.
7. Kawashiro N, Tsuchihashi N, Koga K, Kawano T, Itoh Y. Delayed post-neonatal intensive care unit hearing disturbance. International Journal of Pediatric Otorhinolaryngology 1996;34:35-43.
8. Hendricks-Munoz KD, Walton JP. Hearing loss in infants with persistent fetal circulation. Pediatrics 1988;81:650-6.
9. Walton JP, Hendricks-Munoz K. Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn. J Speech Hear Res 1991;34:1362-70.
10. Kuga T, Taniguchi S, Inoue T, Zempo N, Esato K. Hearing loss in infants with congenital diaphragmatic hernia treated without extracorporeal membrane oxygenation: report of two cases. J Pediatr Surg 2000;35:621-3.
11. Rasheed A, Tindall S, Cueny DL, Klein MD, Delaney-Black V. Neurodevelopmental outcome after congenital diaphragmatic hernia: extracorporeal membrane oxygenation before and after surgery. J Pediatr Surg 2001;36:539-44.
12. Cheung P-Y, Magathan-Haluschak M, Finer NN, Robertson CMT. Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation. Early Hum Dev 1996;44:225-33.
13. Lasky RE, Wiorek L, Becker TR. Hearing loss in survivors of neonatal extracorporeal membrane oxygenation (ECMO) therapy and high-frequency oscillatory (HFO) therapy. J Am Acad Audiol 1998;9:47-58.
14. Robertson CMT, Cheung P-Y, Magathan-Haluschak M, Elliott CA, Leonard NJ, the Western Canadian ECMO Follow-up Group. High prevalence of sensorineural hearing loss among survivors of neonatal congenital diaphragmatic hernia. Am J Oto 1998;19:730-6.
15. Cheung P-Y, Tyebkhan JM, Peliowski A, Ainsworth W, Robertson CMT. Prolonged use of pancuronium bromide and sensorineural hearing loss in childhood survivors of congenital diaphragmatic hernia. J Pediatr 1999;135:233-9.
16. Robertson CMT, Tyebkhan JM, Hagler ME, Cheung P-Y, Peliowski A, Etches PC. Late-onset, progressive sensorineural hearing loss after severe neonatal respiratory failure. Oto Neurotol 2002;23:353-6.
17. American Speech-Language-Hearing Association. Guidelines for the audiologic management of individuals receiving cochliotoxic drug therapy. ASHA 1994;36:11-9.
18. Brown DR, Watcho JF, Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case-controlled study. Dev Med Child Neurol 1991;33:816-23.
19. Compendium of Pharmaceutical and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa, ON: Canadian Pharmacists Association; 2003. p. 86-8, 553-4, 684-6, 871-2, 1807-9.
20. Young TE, Mangum OB. Neofax®: A manual of drugs used in neonatal care. 11th ed. Raleigh, NC: Acorn Publishing; 1998. p. 32-3, 58-9, 66-7, 142-3, 150-1.
21. Shulman A. The cochleovestibular system/ototoxicity/clinical issues. Ann N Y Acad Sci 1993;884:433-6.
22. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Eng J Med 1997;336:597-604.
23. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide study group (NINOS). J Pediatr 2000;136:611-7.
24. American Speech-Language Hearing Association. Guidelines for identification audiometry. ASHA 1985;27:49-52.
25. Stach BA. The nature of hearing impairment. In: Clinical audiology. An introduction. San Diego: Singular Publishing Group; 1998. p. 89-116.
26. Surenthiran SS, Wilbraham K, May J, Chant T, Emmerson AJB, Newton VE. Noise levels within the ear and post-nasal space in neonates in intensive care. Arch Dis Child Fetal Neonatal Ed 2003;88:F315-8.
27. Cheung P-Y, Fyfe K, Etchs P, Peliowski A, Vickar D, Robertson C. Vibration during high frequency ventilation in neonates. Thorax 2001;56:817-8.
28. Bohne BA, Harding GW. Degeneration in the cochlea after noise damage: primary versus secondary events. Am J Oto 2000;21:505-9.
29. Borg E, Counter SA. The middle ear muscles. Scientific American 1989;8:74-80.
30. Prasher D. New strategies for prevention and treatment of noise-induced hearing loss. Lancet 1998;352:1240-2.
31. Humes HD. Insights into ototoxicity, analogies to nephrotoxicity. Ann N Y Acad Sci 1999;884:15-8.
32. Rybak L. Ototoxicity of loop diuretics. Otolargyngol Clin N Am 1993;26:829-44.
33. Ding D, McFadden SL, Woo JM, Salvi RJ. Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea. Hearing Research 2002;173:1-9.
34. Kopke R, Allen KA, Henderson D, Hoffer M, Frenz D, Van De Water T. A radical demise. Toxins and trauma share common pathways in hair cell death. Ann N Y Acad Sci 1999;884:171-91.
35. Halpern NA, Pastores SM, Price JB, Alicea M. Hearing loss in critical care: an unappreciated phenomenon. Crit Care Med 1999;27:211-9.
36. Aran J-M, Erre J-P, Da Costa DL, Debbarh I, Dulon D. Acute and chronic effects of aminoglycosides on cochlear hair cells. Ann N Y Acad Sci 1999;884:60-8.
37. de Hoog M, van Zanten BA, Hop WC, Overbosch E, Weisglas-Kuperus N, van den Anker JN. Newborn hearing screening: Tobramycin and Vancomycin are not risk factors for hearing loss. J Pediatr 2003;142:41-6.
38. de Hoog M, van Zanten GA, Haene LJ, Blom AM, van den Anker JN. A pilot case control follow-up study on hearing in children treated with tobramycin in the newborn period. Int J Pediatr Otorhinolaryngol 2003;65:225-32.
39. Matz GJ. Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am 1993;26:705-12.
40. Brummett RE. Drug-induced ototoxicity. Drugs 1980;19:412-28.
41. Duffell SB, Begg EJ. Vancomycin toxicity. What is the evidence for dose dependency? Adverse Drug React Toxicol Rev 1994;13:103-14.
42. Garcia VP, Martinez FA, Agusti EB, Mencia LA, Asenjo VP. Drug-induced ototoxicity: current status. Acta Otolargyngol 2001;121:569-72.
43. Gorga MP, Neely ST, Dorn PA. Distortion product otoacoustic emissions in relation to hearing loss. In: Robinette MS, Glattke TJ, editors. Otoacoustic emissions: clinical applications, 2nd edn. New York, NY: Theme Medication Publications; 2002. p. 243-72.
44. Boloker J, Bateman DA, Wung J-T, Stokes CJH. Congenital Diaphragmatic Hernia in 120 infants treated with permissive hypercapnea, spontaneous respiration, and elective repair. J Pediatr Surg 2002;37:357-66.